Mep-Orva Eye Drop
By Mep-Orva
5ml Eye Drop in a Bottle
Composition
Ofloxacin(0.3% w/v)
Manufacturer - Mepfarma India Pvt Ltd
SCF-270, Motor Market, Manimajra, CHANDIGARH 160 101 India
Expires on or after
July, 2025
When considering the safety of Mep-Orva Eye Drop in relation to liver issues, it is important to note that no interactions have been found or established so far. This means that there is currently no known specific caution or advice regarding the use of Mep-Orva Eye Drop related to liver health. It is advisable to always consult with your doctor for proper guidance before using Mep-Orva Eye Drop to ensure the best course of action for your individual health needs.
No interaction found with kidney related issues.
No interaction found between alcohol and Mep-Orva Eye Drop. Monitor caution during pregnancy.
If you experience decreased alertness, vision changes, sleepiness, or dizziness while using Mep-Orva Eye Drop, avoid driving. These effects can impair your ability to drive safely.
Mep-Orva Eye Drop may not be safe to use during pregnancy. Limited studies in humans suggest potential harm to the developing baby based on animal studies. Consult your doctor to understand the benefits and risks before using this medication.
It is not recommended to use Mep-Orva Eye Drop while breastfeeding. Limited evidence indicates potential harm to the baby through breastmilk transmission.
Habit Forming | No |
Chemical Class | Fluoroquinolone |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Quinolones/ Fluroquinolones |
₹35
Inclusive of all taxes
Content verified by
Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025